Legal Representation
Attorney
Perla M. Kuhn
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 26, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 25, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 23, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 23, 2008 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 23, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 30, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 24, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 24, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 23, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 23, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 24, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 30, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 10, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 15, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 15, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 30, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 29, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 3, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of all types of obesity as well as all problems that normally accompany obesity; cellulitis; all types of inflammatory and degenerative processes of organs and especially the locomotor system; traumatic injuries and microtraumatic injuries; flaccidity; premature aging; aging of the skin; general exhaustion; arteriosclerosis, chronic or introgenetic; illnesses from abuse of antibiotics or corticoids; post-traumatic muscular recovery and muscular dystrophy; anaemia; treatment of all venal related pathologies, lymphatic and arterial conditions; cystitis and related conditions; chronic edematous prostate; gallstones; antiseptics for the urinary tracts, vertebral-vasilar deficiencies; dysmenorrhea; diabetic retinopathy; treatment of all kinds of edemas; colds; problems in the gastric/hepatic/biliary system; all types of osteoarticular and neurological pathologies; skin pathologies; hair problems; depression; seasonal emotional disorders; psychosomatic disorders; emotional instability; sleep disorders; anxiety; stress; alcohol and tobacco detoxification; pharmaceutical preparations to increase the synthesis of muscle mass; vitamin and mineral supplements
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005